Iris prolapse is a condition in which the iris, the colored part of the eye, bulges forward and causes a visible “prolapse”. This condition can be caused by eye trauma or surgery, though it is most common among those born with certain congenital ocular anomalies. In this blog post, we will discuss what causes iris prolapse, how to diagnose it and the various approaches to treating it. By arming yourself with this knowledge you will be able to better help your patients manage their symptoms and live life more comfortably.
The iris is the colored part of the eye that surrounds the pupil. The pupil is the black center of the eye, which gets bigger or smaller to let in more or less light. The iris controls how much light enters the eye. Iris prolapse happens when part of the iris bulges forward into the pupil. This can happen because of an injury, trauma, surgery, or other condition that weakens the muscles or tissues around the eye. Iris prolapse can also happen on its own, without any known cause.
-Eye pain
-Sensitivity to light
-Blurry vision
-The appearance of a “halo” around lights
-The feeling that there is something in your eye
The iris is the colored part of the eye that controls how much light enters the eye. It is made up of two layers: the front layer, called the epithelium, and the back layer, called the stroma. The stroma contains collagen fibers and pigmented cells that give the iris its color. The space between the epithelium and stroma is filled with a clear gel-like substance called the aqueous humor. The iris prolapse can be caused by different things. One cause can be due to trauma or injury to the eye which causes the tissues to become weak or stretched. This can happen from a blow to the head or face, an accident, or even surgery on the eye. Another cause of iris prolapse can be due to certain diseases such as glaucoma, diabetes, or other conditions that increase pressure inside the eye. This extra pressure can cause the iris tissue to become weak and eventually lead to prolapse.
Most cases of iris prolapse can be treated with surgery to reposition the iris. In some cases, a contact lens may be used to protect the exposed surface of the eye. If there is significant damage to the eye, a corneal transplant may be necessary. Treatment usually involves operating to put the iris back in place and repairing any damage to the eye.
Iris prolapse is a common eye disorder that affects the eyes of many people. It is important for medical professionals to be familiar with the causes, diagnosis and treatment options available so they can properly advise and treat patients. By knowing how iris prolapse presents itself and understanding the risks associated with surgery, medical personnel can better address any concerns a patient may have in relation to this condition. With proper care, it's possible for individuals affected by iris prolapse to achieve satisfactory outcomes both medically and aesthetically.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation